Tag - Echelon

Markets

Echelon ups Extendicare to buy; holds PT at $9

Echelon Wealth Partners upgraded Extendicare (TSX:EXE) to “buy” from “hold” but kept its price target at $9 after the company reported fourth quarter results. The stock closed at $7.85 (Canadian) on March 2. Analyst...

March 3, 2020

Markets

Analysts downgrade Correvio Pharma as FDA Adcom rejects Brinavess

Analysts for H.C. Wainwright, Mackie Research and Echelon Wealth Partners downgraded Correvio Pharma (NASDAQ:CORV) after the FDA Cardiovascular and Renal Drugs Advisory Committee voted 11-2 against recommending approval...

December 11, 2019

Markets

Echelon cuts Medical Facilities PT to $5.50 from $10

Echelon Wealth Partners slashed its price target for Medical Facilities (TSX:DR) to $5.50 from $10 and maintained its “hold” rating after the company reported third quarter results that included a dramatic dividend cut...

November 8, 2019

Tag - Echelon

Echelon ups Extendicare to buy; holds PT at $9

Analysts downgrade Correvio Pharma as FDA Adcom rejects Brinavess

Echelon cuts Medical Facilities PT to $5.50 from $10

General

More